Alpha Capital Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-34,328
Closed -$13K 107
2019
Q4
$13K Hold
34,328
﹤0.01% 101
2019
Q3
$20K Hold
34,328
0.01% 98
2019
Q2
$29K Hold
34,328
0.01% 95
2019
Q1
$34K Hold
34,328
0.01% 91
2018
Q4
$28K Buy
34,328
+600
+2% +$1.18K 0.01% 90
2018
Q3
$94K Hold
33,728
0.04% 88
2018
Q2
$95K Buy
33,728
+10,500
+45% +$31.2K 0.04% 88
2018
Q1
$47K Buy
23,228
+13,100
+129% +$28.4K 0.02% 86
2017
Q4
$23K Hold
10,128
0.01% 91
2017
Q3
$22K Hold
10,128
0.01% 88
2017
Q2
$22K Buy
+10,128
New +$24.8K 0.01% 92

Other funds holding SPHS

Alpha Capital Management's SPHS Position: Q1 2020 in Review

Alpha Capital Management sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 34,328 shares — an estimated $13K sold.

Alpha Capital Management first reported a position in SPHS in Q2 2017 and held it in 11 quarters. The position peaked at $95K in Q2 2018. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

  • Alpha Capital Management reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
  • Alpha Capital Management sold 34,328 Sophiris Bio, Inc. shares in Q1 2020, an estimated $13K.
  • Alpha Capital Management first reported a position in Sophiris Bio, Inc. in Q2 2017 and held it in 11 quarters.
  • Alpha Capital Management's Sophiris Bio, Inc. position peaked at $95K in Q2 2018.
  • 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Alpha Capital Management's 13F filing for Q1 2020, filed 5 May 2020.